Related Experiment Video
Updated: Jul 28, 2026
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Light and scanning-electron microscopic examination of coronary stents in a perfusion-model. Effects of an
R P Franke1, P Reuter, C Mrowietz
1Department of Biomaterials, University of Ulm, Albert-Einstein-Allee 47, 89081 Ulm, Germany.
Insights
Nitric oxide (NO)-donors, like molsidomine, significantly reduce platelet adherence and aggregation on coronary stents. This NO-donor therapy improves stent performance by altering platelet interaction with stent surfaces.
Area of Science:
- Cardiovascular Research
- Biomedical Engineering
- Pharmacology
Background:
- Platelet adherence and aggregation on coronary stents are critical factors in stent thrombosis and restenosis.
- Nitric oxide (NO) is known to possess anti-platelet properties.
- Understanding the effect of NO-donors on stent-platelet interactions is crucial for improving stent design and antithrombotic strategies.
Purpose of the Study:
- To investigate whether a nitric oxide (NO)-donor attenuates platelet adherence and aggregation on coronary stents.
- To evaluate the impact of NO-donor administration in a closed-loop perfusion model with stented surfaces.
Main Methods:
- Utilized a closed-loop perfusion model to simulate blood flow conditions.
- Implanted coronary stents within the perfusion model.
- Administered SIN-1 (active metabolite of molsidomine), a NO-donor, and observed its effects using light and scanning electron microscopy.
Main Results:
- The NO-donor SIN-1 markedly reduced platelet adherence to stent surfaces.
- Platelet distribution shifted, with more adherence to the stent backbone and less to free modular parts.
- SIN-1 also significantly reduced platelet aggregation, characterized by a spheroidic shape change.
Conclusions:
- Nitric oxide-donors effectively attenuate platelet adherence and aggregation on coronary stents.
- This NO-donor therapy demonstrates potential for improving stent biocompatibility and reducing thrombotic complications.
- The findings suggest a therapeutic benefit of NO-donors in interventional cardiology.
Abstract:
Does a NO-donor (Corvaton, Aventis, France) attenuate the adherence and the aggregation of platelets in a closed-loop perfusion modell with or without the implantation of coronary stents? SIN-1, the active metabolite of molsidomine, exerted a strong influence on the interaction of platelets with the surfaces of stents. When SIN-1 was added the adherence of platelets to the surfaces of stents was markedly reduced. The sites were most of the platelets adhered to, also changed. More platelets adhered to the stent backbone and less to the free modular stent parts. The localisation of adherent platelets could easily be shown by light microscopy. The aggregation of platelets, accompanied by a spheroidic shape change, could be demonstrated by scanning electron microscopy on the addition of an NO-donor, not only a reduction of platelet adherence was realised but also the reduction of platelet aggregation.
